Biotechnology

Molecular Templates

Molecular Templates, Inc. Announces 2024 Second Quarter Financial Results and Company Updates

Molecular Templates, Inc. Updates Clinical Projects, MT-6402 and MT-0169 Show Potential

Top Wealth

Orangekloud Tech

Wave Life Sciences

Cemtrex

Webuy Global

Structure Therapeutics

Biodexa Pharmaceuticals

Creative Media & Community Trust

Fulcrum Therapeutics

Kymera Therapeutics

Adma Biologics

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel Pharma

OpGen

Vertex Pharma

Regeneron Pharma

Alnylam Pharma

Argenx

Beigene

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap